Conference Call and Webcast to Follow
WASHINGTON, April 28, 2022 /PRNewswire/ -- Vanda
Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will
release results for the first quarter 2022 on Thursday, May 5, 2022, after the market closes.
Vanda will host a conference call at 4:30
PM ET on Thursday, May 5, 2022, during which management will
discuss the first quarter 2022 financial results and other
corporate activities. To participate in the conference call, please
dial 1-866-688-9426 (domestic) or 1-409-216-0816
(international) and use passcode 1355275.
The conference call will be broadcast simultaneously and
archived on Vanda's website, www.vandapharma.com. Investors should
go to the website at least 15 minutes early to register, download,
and install any necessary audio software.
A replay of the call will be available on Thursday, May 5, 2022, beginning at 7:30 PM ET and will be accessible until
Thursday, May 12, 2022, at
7:30 PM ET. The replay call-in number
is 1-855-859-2056 for domestic callers and 1-404-537-3406 for
international callers. The passcode number is 1355275.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on
the development and commercialization of innovative therapies to
address high unmet medical needs and improve the lives of patients.
For more on Vanda Pharmaceuticals Inc., please visit
www.vandapharma.com and follow us on Twitter @vandapharma.
Corporate Contact:
Kevin
Moran
Senior Vice President, Chief Financial Officer and
Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Elizabeth Van Every
Head of Corporate Affairs
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
View original
content:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-first-quarter-2022-financial-results-on-may-5-2022-301535879.html
SOURCE Vanda Pharmaceuticals Inc.